Saudi Health

Saudi Arabia’s Ministry of Health has awarded London’s Sovereign Strategy a $3M pact to position the Kingdom as a thought leader on antimicrobial resistance by 2030.

Vision 2030 is the Crown Prince Mohammed bin Salman’s economic and technological development plan to modernize the Kingdom.

The World Health Organization has called AMR one of the top global health and development threats.

AMR occurs when bacteria, viruses, fungi and parasites no longer respond to antimicrobial medicines.

Due to the resistance, medicines become ineffective, increasing the spread of disease, severe illnesses, disability and death.

Saudi Arabia will host the Fourth Global High-level Ministerial Meeting on Antimicrobial Resistance slated for Riyadh on Nov. 4-5.

Sovereign, which has a 15-month pact, will support the Ministry's bid to build a successful political engagement strategy on AMR and develop innovative and concrete initiatives that it can present in the lead-up, during and the aftermath of the Ministerial Meeting, according to the contract.

It will help with the Ministerial Meeting’s final communique to include special goals with clear metrics and timelines.

Sovereign believes a successful meeting will burnish Saudi Arabia’s reputation in the world of AMR.

It also will handle outreach to the US-based Biomedical Advanced Research and Development Authority and biotech companies to develop partnerships with the Saudis.